SPARC signs licensing deal with Visiox for two ophthalmic drug candidates
Sun Pharma Advanced Research Company (SPARC) has signed a licensing agreement with Visiox Pharma to award exclusive worldwide rights (except for India and Greater China) for developing and commercializing its ophthalmic drug candidates — PDP-716 and SDN-037. As per the terms of the licensing deal, Sun Pharma Advanced Research Company will be entitled to get […]